Furthermore, differentiation of BTBGD-iPSCs toward disease-relevant lineages, such as neuronal subtypes and midbrain organoids, would serve as a powerful cellular platforms to determine the impact of SLC19A3 deficiency and the underlying disease mechanism in BTBGD. The gene discussed is SLC19A3; the disease is biotin-responsive basal ganglia disease.